Twist Bioscience

YTD

ALL

Trade Twist Bioscience 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About TWST

Twist Bioscience Corp. engages in the development of a proprietary semiconductor-based synthetic DNA manufacturing process. It operates through the following geographical segments: Americas, EMEA, and APAC.

CEO

Emily Marine Leproust

CEOEmily Marine Leproust

Employees

979

Employees979

Headquarters

San Francisco, California

HeadquartersSan Francisco, California

Founded

2013

Founded2013

Employees

979

Employees979

TWST Key Statistics

Market cap

3.60B

Market cap3.60B

Price-Earnings ratio

-43.09

Price-Earnings ratio-43.09

Dividend yield

—

Dividend yield—

Average volume

1.70M

Average volume1.70M

High today

$56.00

High today$56.00

Low today

$50.36

Low today$50.36

Open price

$54.12

Open price$54.12

Volume

1.38M

Volume1.38M

52 Week high

$57.88

52 Week high$57.88

52 Week low

$23.30

52 Week low$23.30

Stock Snapshot

Twist Bioscience(TWST) stock is priced at $50.36, giving the company a market capitalization of 3.6B. It carries a P/E multiple of -43.09.

On 2026-02-19, Twist Bioscience(TWST) stock moved within a range of $50.36 to $56.00. With shares now at $50.36, the stock is trading 0.0% above its intraday low and -10.1% below the session's peak.

Trading activity shows a volume of 1.38M, compared to an average daily volume of 1.7M.

Over the past 52 weeks, Twist Bioscience(TWST) stock has traded between a high of $57.88 and a low of $23.30.

TWST News

Simply Wall St 8h

Twist Bioscience Deepens Bispecific Antibody Push With Invenra Tie Up

Twist Bioscience (NasdaqGS:TWST) has entered a co-exclusive licensing agreement for Invenra's bispecific antibody platform. The deal includes an equity stake i...

TipRanks 23h

Twist Bioscience Insider Makes Notable Move With Fresh Stock Sale

New insider activity at Twist Bioscience ( (TWST) ) has taken place on February 18, 2026. Director Robert Chess has cashed out a portion of his holdings in Twi...

Simply Wall St 2d

Twist Bioscience Expands Antibody And Genomics Tools As Valuation Stays Stretched

Twist Bioscience (NasdaqGS:TWST) agreed to license Invenra’s B-Body bispecific antibody platform on a co exclusive basis, while also taking an equity stake and...

Analyst ratings

82%

of 11 ratings

Buy

81.8%

Hold

18.2%

Sell

More TWST News

TipRanks 3d

Twist Bioscience enters licensing agreement with Invenra

Twist Bioscience (TWST) announced that it has entered into a licensing agreement with Invenra. Under the terms of the agreement, Twist will become the co-exclus...

TipRanks 3d

Twist Bioscience Expands Invenra Stake Through Equity Transactions

Twist Bioscience ( (TWST) ) has issued an update. On February 11, 2026, Twist Bioscience Corporation agreed to issue up to 632,328 shares of common stock as pa...

Simply Wall St 7d

Twist Bioscience Valuation Check After New Sequencing Kits Expand Genomics Offering

Twist Bioscience (TWST) has attracted fresh attention after launching its TrueAmp Library Preparation Kit and PCR Free WGS Library Preparation Kit, broadening i...

People also own

Based on the portfolios of people who own TWST. This list is generated using Robinhood data, and it’s not a recommendation.

CRISPR

Block

Intellia Therapeutics

Shopify

Coinbase

AMD

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.